-transparent.png){kind=logo}
Three recently synthesized dihydrofolate reductase (DHFR) inhibitors designated SoRI 8890, 8895, and 8897 were evaluated for their in vitro activities against 25 isolates of Mycobacterium avium complex. The MICs at which 50 and 90% of isolates were inhibited were 1 and 2, 4 and 8, and 4 and 8 microgram/ml for SoRI 8890, 8895, and 8897, respectively. Although the addition of dapsone at 0.5 microgram/ml did not significantly enhance the in vitro activities of these compounds, their activities alone were comparable to, if not better than, results seen with other DHFR inhibitors, such as pyrimethamine or WR99210.
Related Publications
C M Shoen, and
O Choromanska, and
R C Reynolds, and
J R Piper, and
C A Johnson, and
M H Cynamon
September 1989,
Antimicrobial agents and chemotherapy,
C M Shoen, and
O Choromanska, and
R C Reynolds, and
J R Piper, and
C A Johnson, and
M H Cynamon
August 1994,
International journal of antimicrobial agents,
C M Shoen, and
O Choromanska, and
R C Reynolds, and
J R Piper, and
C A Johnson, and
M H Cynamon
February 1987,
Diagnostic microbiology and infectious disease,
C M Shoen, and
O Choromanska, and
R C Reynolds, and
J R Piper, and
C A Johnson, and
M H Cynamon
December 1990,
Kekkaku : [Tuberculosis],
C M Shoen, and
O Choromanska, and
R C Reynolds, and
J R Piper, and
C A Johnson, and
M H Cynamon
May 1995,
The Journal of antimicrobial chemotherapy,
C M Shoen, and
O Choromanska, and
R C Reynolds, and
J R Piper, and
C A Johnson, and
M H Cynamon
February 1993,
Archives of internal medicine,
C M Shoen, and
O Choromanska, and
R C Reynolds, and
J R Piper, and
C A Johnson, and
M H Cynamon
October 2021,
Journal of medical microbiology,
C M Shoen, and
O Choromanska, and
R C Reynolds, and
J R Piper, and
C A Johnson, and
M H Cynamon
March 1988,
Kekkaku : [Tuberculosis],
C M Shoen, and
O Choromanska, and
R C Reynolds, and
J R Piper, and
C A Johnson, and
M H Cynamon
February 2017,
Antimicrobial agents and chemotherapy,
C M Shoen, and
O Choromanska, and
R C Reynolds, and
J R Piper, and
C A Johnson, and
M H Cynamon
September 1989,
Antimicrobial agents and chemotherapy,
